Dr. Jimmy Roehrig M.S. ’88 has joined Matakina International, a leader in the development of objective volumetric measurement of breast density. Roehrig will provide scientific depth to the U.S. sales effort and strategic planning for product development and intellectual property, particularly with the software Volpara, designed to help overcome the limitations of mammography to detect cancer in women with dense breasts; it generates objective, automatic measurement of volumetric breast density values along with a BI-RADS Breast Density Classification for mammograms acquired from any commercially available digital mammography system.

Roehrig, who co-founded R2 Technology, served as chief science officer and was responsible for building the technical team that produced the ImageChecker® computer-aided detection (CAD) system, the first CAD system approved by the FDA. As VP of Advanced Development, Dr. Roehrig led the development and refinement of R2’s proprietary algorithm for the earlier detection of breast cancer and managed efforts to apply the technology to other diseases. Upon the acquisition of R2 by Hologic, Inc, Dr. Roehrig remained until 2012, working primarily in the field of quantitative DCE MRI for breast imaging.